Anavex Life Sciences Corp (AVXL)

[nidan7500]

dado...agree w/your connecting the dots. Today's PR includes a few more clues to support your thought. No only does the PR mention the 3 trials about to start(just in case we forgot or thought maybe not), and in mentions interconnected thought. First time I ever saw that in print and a "tip of the iceberg" comment. CNS still Homeostasis presents an uncontradicted thesis. Additionally, we just hired another giant who is well informed and who could have walked away but did not. Semper fi...keep swinging doc.

""I am impressed with Anavex and its potential CNS platform drug, ANAVEX 2-73, which has shown encouraging clinical safety data combined with promising preclinical anti-seizure data," said Andrew J. Cole, M.D., F.R.C.P.(C.), Director of the Massachusetts General Hospital Epilepsy Service and Professor of Neurology at Harvard Medical School. “I look forward to advising the company as it’s about to initiate three clinical trials with significant unmet needs.”
“We are pleased to welcome Dr. Andrew Cole to Anavex’s Scientific Advisory Board,” stated Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “Dr. Cole brings extensive experience in neurological diseases to Anavex. I am confident he will make important contributions to our SAB and to the continued development of ANAVEX 2-73 for the treatment of both neurodevelopmental and neurodegenerative diseases, including Rett syndrome, Parkinson’s disease and Alzheimer’s disease.”